Enoki Eisuke
Clinical Research Center, Kinki University Hospital.
Yakugaku Zasshi. 2018;138(4):459-464. doi: 10.1248/yakushi.17-00181-1.
Cases of research misconduct (fabrication, falsification, and plagiarism) have been increasing worldwide, including in Japan. In particular, since 2006, many cases of research misconduct have been reported in Japan, and these cases have also been covered by the media. The 2014 case of the withdrawal of articles on STAP cells followed a rare course in which research misconduct became a full-blown social phenomenon. In recent years, even the University of Tokyo has experienced reported cases of research misconduct. In this report, I would like to introduce some representative cases of research misconduct in the field of life sciences over the past decade. These examples include studies conducted at Osaka University Graduate School of Medicine (2006), Osaka University Graduate School of Frontier Bioscience (2006), Ryukyu University School of Medicine (2010), Toho University School of Medicine (2012), The University of Tokyo Institute of Molecular and Cellular Biosciences (2013), and several cases outside of Japan. I will discuss what researchers should do to reduce the incidence of research misconduct. In addition, I will discuss how these cases were covered by the media, because the public's impression of research misconduct is formed by media coverage.
包括在日本在内,研究不端行为(伪造、篡改和剽窃)的案例在全球范围内不断增加。特别是自2006年以来,日本报道了许多研究不端行为的案例,这些案例也受到了媒体的关注。2014年有关STAP细胞文章撤回的案例,呈现出一种罕见的情况,即研究不端行为演变成了一种全面的社会现象。近年来,就连东京大学也出现了研究不端行为的报道案例。在本报告中,我想介绍过去十年生命科学领域一些具有代表性的研究不端行为案例。这些例子包括大阪大学医学研究生院(2006年)、大阪大学前沿生物科学研究生院(2006年)、琉球大学医学院(2010年)、东邦大学医学院(2012年)、东京大学分子与细胞生物科学研究所(2013年)开展的研究,以及日本境外的一些案例。我将讨论研究人员应该采取什么措施来减少研究不端行为的发生率。此外,我将讨论这些案例是如何被媒体报道的,因为公众对研究不端行为的印象是由媒体报道形成的。